Drugmakers may bear sole responsibility for overpricing essential medicines under NPPA proposal

The National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential medications. This initiative could shield retail chemists and hospitals from legal repercussions concerning pricing infractions. Manufacturers are likely to challenge the proposal, alleging it is uncompromising and unjust. Previously, substantial penalties have been levied against drugmakers for such transgressions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Jwgi9SV
via IFTTT